Anhua Wei

789 total citations
38 papers, 551 citations indexed

About

Anhua Wei is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anhua Wei has authored 38 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anhua Wei's work include Piperaceae Chemical and Biological Studies (10 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Anhua Wei is often cited by papers focused on Piperaceae Chemical and Biological Studies (10 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Anhua Wei collaborates with scholars based in China, United States and Netherlands. Anhua Wei's co-authors include Jinlan Ruan, Zhi‐Chun Gu, Jun Pu, Daonian Zhou, Yaling Cai, Xiaoyan Liu, Chaomei Xiong, Juan Li, Xiaofan Wu and Yi Han and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Journal of Ethnopharmacology.

In The Last Decade

Anhua Wei

35 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anhua Wei China 13 174 143 94 79 69 38 551
Anna Komosa Poland 14 256 1.5× 48 0.3× 99 1.1× 44 0.6× 43 0.6× 43 465
Paloma Gallego Spain 12 74 0.4× 272 1.9× 39 0.4× 59 0.7× 34 0.5× 14 666
Seung Hwan Hwang South Korea 12 114 0.7× 66 0.5× 34 0.4× 19 0.2× 28 0.4× 26 407
Bryan J. Brinda United States 9 96 0.6× 133 0.9× 131 1.4× 145 1.8× 11 0.2× 19 433
Bi‐Lian Chen China 12 130 0.7× 90 0.6× 13 0.1× 144 1.8× 14 0.2× 21 471
Takahiro Hayashi Japan 13 21 0.1× 80 0.6× 47 0.5× 77 1.0× 36 0.5× 41 428
Valentina Castellani Italy 12 82 0.5× 111 0.8× 22 0.2× 17 0.2× 19 0.3× 31 565
Antonina Ganci Italy 14 428 2.5× 138 1.0× 77 0.8× 81 1.0× 36 0.5× 28 1.2k
T. W. B. Gehr United States 12 135 0.8× 161 1.1× 61 0.6× 28 0.4× 30 0.4× 20 585
Tungming Leung United States 9 35 0.2× 123 0.9× 21 0.2× 60 0.8× 15 0.2× 18 656

Countries citing papers authored by Anhua Wei

Since Specialization
Citations

This map shows the geographic impact of Anhua Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anhua Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anhua Wei more than expected).

Fields of papers citing papers by Anhua Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anhua Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anhua Wei. The network helps show where Anhua Wei may publish in the future.

Co-authorship network of co-authors of Anhua Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Anhua Wei. A scholar is included among the top collaborators of Anhua Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anhua Wei. Anhua Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Wen, et al.. (2025). Machine Learning-Driven Discovery of TRIM Genes as Diagnostic Biomarkers for Idiopathic Pulmonary Fibrosis. Medical Science Monitor. 31. e948510–e948510.
2.
Liu, Jinyu, et al.. (2023). Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review. Frontiers in Pharmacology. 14. 1186579–1186579. 1 indexed citations
3.
Li, Lin, et al.. (2023). Association between immune-related adverse events and immunotherapy efficacy in non-small-cell lung cancer: a meta-analysis. Frontiers in Pharmacology. 14. 1190001–1190001. 23 indexed citations
4.
5.
Gui, Lin, et al.. (2023). Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1143444–1143444. 12 indexed citations
6.
Li, Lin, et al.. (2023). Peripherally inserted central catheters versus implantable port catheters for cancer patients: a meta-analysis. Frontiers in Oncology. 13. 1228092–1228092. 9 indexed citations
8.
Tang, Bo‐Hao, et al.. (2022). Effect of drug combination on tacrolimus target dose in renal transplant patients with different CYP3A5 genotypes. Xenobiotica. 52(3). 312–321. 3 indexed citations
9.
Feng, Zhanchun, et al.. (2022). Does Having a Usual Primary Care Provider Reduce Polypharmacy Behaviors of Patients With Chronic Disease? A Retrospective Study in Hubei Province, China. Frontiers in Pharmacology. 12. 802097–802097. 8 indexed citations
10.
Wei, Anhua, et al.. (2021). HPLC Quantification of Flavonoids from Macrothelypteris viridifrons. Revista Brasileira de Farmacognosia. 31(4). 492–496. 1 indexed citations
11.
Gu, Zhi‐Chun, Lingcong Kong, Shuofei Yang, et al.. (2019). Net clinical benefit of non-vitamin K antagonist oral anticoagulants in atrial fibrillation and chronic kidney disease: a trade-off analysis from four phase III clinical trials. Cardiovascular Diagnosis and Therapy. 9(5). 410–419. 12 indexed citations
12.
Gu, Zhi‐Chun, Anhua Wei, Chi Zhang, et al.. (2019). Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 18(4). 792–799.e61. 64 indexed citations
13.
Wei, Anhua, Daonian Zhou, Zhi‐Chun Gu, & Dong Liu. (2018). HPLC analysis, optimization of extraction and purification conditions, biological evaluation of total protoflavones from Macrothelypteris viridifrons. Natural Product Research. 33(21). 3167–3170. 1 indexed citations
15.
Gu, Zhi‐Chun, Anhua Wei, Min Cui, et al.. (2017). Incidence and risk of respiratory tract infection associated with specific drug therapy in pulmonary arterial hypertension: a systematic review. Scientific Reports. 7(1). 16218–16218. 9 indexed citations
17.
Fang, Wei, Jinlan Ruan, Yaling Cai, et al.. (2011). Flavonoids from the aerial parts ofMacrothelypteris torresiana. Natural Product Research. 25(1). 36–39. 13 indexed citations
18.
Liu, Huibin, Yuling Xiao, Chaomei Xiong, Anhua Wei, & Jinlan Ruan. (2011). Apoptosis induced by a new flavonoid in human hepatoma HepG2 cells involves reactive oxygen species-mediated mitochondrial dysfunction and MAPK activation. European Journal of Pharmacology. 654(3). 209–216. 40 indexed citations
19.
Wei, Anhua, Daonian Zhou, Chaomei Xiong, Yaling Cai, & Jinlan Ruan. (2011). A novel non-aromatic B-ring flavonoid: Isolation, structure elucidation and its induction of apoptosis in human colon HT-29 tumor cell via the reactive oxygen species-mitochondrial dysfunction and MAPK activation. Food and Chemical Toxicology. 49(9). 2445–2452. 19 indexed citations
20.
Wei, Anhua, Daonian Zhou, Jinlan Ruan, et al.. (2011). Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC–DAD/MS analysis. Journal of Ethnopharmacology. 139(2). 373–380. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026